Cancer Biology

oncoprotein signaling networks

• Email: hema.adhikari@wustl.edu

Identification of new targets to improve tumor radiation effectiveness and to protect normal tissues such as the heart from radiation injury

• Email: acbergom@wustl.edu

The interplay between inherited genetic variation, environmental factors, and acquired mutations in shaping the earliest stages of carcinogenesis

• Email: bolton@wustl.edu

Tyrosine Kinase Signaling in Breast Cancer

• Email: rbose@dom.wustl.edu

Immunotherapy, brain tumor, spinal cord tumor, high grade gliomas

• Email: jcampian@dom.wustl.edu

Liquid biopsy cancer detection

• Email: aadel@wustl.edu

Understanding T cells and immunoregulatory networks in GvHD and GvL for the treatment of hematopoietic malignancies

• Email: jchoi25@wustl.edu

Cancer Proteogenomics and Cancer Models

• Email: lding@wustl.edu

We use both mouse models and patient samples of acute myloid leukemia to understand leukemogenesis and to identify novel therapeutic targets.

• Email: ferrarof@wustl.edu

Metabolism of cancer, targeting tumor metabolism by blocking metabolic pathways

• Email: matthewlgoodwin@wustl.edu

cancer, metabolism, imaging, sex differences, glioblastoma

• Email: ippolitoj@wustl.edu

• Twitter

Hematopoietic stem cells, Multipotent progenitor, Cell fate decision, Lineage specification

• Email: yoonakang@wustl.edu

prognosis and response to radiation therapy, therapeutic targets for cervical and anal cancers

• Email: smarkovina@wustl.edu

Epigenetics, Chromatin, Genomics, Gene Regulation, Cell fate, Transcription Factors

• Email: meers@wustl.edu

Dendritic cells control adaptive immune responses

• Email: kmurphy@wustl.edu

To understand the metabolic crosstalk between cells and tissues in disease models such as cancer by using isotopes and metabolomics

• Email: gjpattij@wustl.edu

Role of Senescent T cells in tumor and neurodegeneration; tumor-associated regulatory T cells (Tregs) in suppression of anti-tumor immunity, Toll-like receptor (TLR) ligands and other immunomodulators; metabolic and epigenetic reprogramming of T cells for immunotherapy

• Email: pengg@wustl.edu

Molecular imaging tools to understand tumor biology and response to therapies

• Email: ribeiropereirap@wustl.edu

tumor biology, signal transduction, stem cells, neural development, sexual dimorphism, circadaian rhythm, chemokines, cAMP

• Email: Rubin_J@wustl.edu

Gynecologic cancers, thyroid cancer, molecular imaging

• Email: jschwarz@wustl.edu

Epigenetics, stem cell radiation response, chromatin and DNA damage response, apoptosis, DNA repair, post-translational histone modifications, oncogenesis.

• Email: sharma@wustl.edu

Antigen-4 (VLA-4) targeted PET radiopharmaceuticals, multiple myeloma, hematopoietic progenitor cells (HPCs), PET, MRI and Optical imaging techniques

• Email: mshokeen@wustl.edu

Long non-coding RNAs and RNA modifications in cancer metastasis and relapse

• Email: silvajm@wustl.edu

The Verma lab studies the causes and consequences of DNA damage in cancers

• Email: vermap@wustl.edu

Cancer, DNA damage response, RNA surveillance, cell cycle, chromatin, laser micro-irradiation, Xenopus egg extracts, imaging, genetically-encoded reporters

• Email: zyou@wustl.edu